This review discusses rhythm management and resynchronization therapy for pediatric and congenital heart disease patients with heart failure, an area where evidence is less established than in adults.
No takes yet. Share an insight, caveat, or question.
Insufficient evidence limits routine pediatric resynchronization; leaves open dedicated trials in congenital heart disease.
Dubin et al. (2006) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: